3 Einträge gefunden

1. Current status and perspectives of tyrosine kinase inhibitor treatment in the post-transplant period in patients with chronic myeloid leukemia (CML).

   1. Klyuchnikov, Evgeny
   2. Kröger, Nicolaus
   3. Brümmendorf, Tim
   4. Wiedemann, Bettina
   5. Zander, Axel R.
   6. Bacher, Ulrike

   2009 - Forschungsinformationssystem des UKE
2. Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib.

   1. Schafhausen, Philippe
   2. Dierlamm, Judith
   3. Bokemeyer, Carsten
   4. Brümmendorf, Tim
   5. Bacher, Ulrike
   6. Zander, Axel R.
   7. Schnittger, Susanne

   2009 - Forschungsinformationssystem des UKE
3. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

   1. Klyuchnikov, Evgeny
   2. Schafhausen, Philippe
   3. Kröger, Nicolaus
   4. Brümmendorf, Tim
   5. Osanmaz, Okay
   6. Asenova, Svetlana
   7. Zabelina, Tatjana

   2009 - Forschungsinformationssystem des UKE